Connect with us
The inflammatory bowel disease market is rapidly growing, driven by unmet patient needs despite existing therapies. Major pharma acquisitions highlight strong demand for innovative treatments. Abivax’s...
Novo Nordisk raised its bid for Metsera to €8.677 billion—11% higher than before—after Pfizer accused it of anti-competitive tactics. Metsera’s board deemed Novo’s offer a “Superior...
Pfizer Spain’s 2024 Impact Report highlights its leadership in clinical research, €54M R&D investment, four new treatments, and 113 trials across 13 areas. Marking Pfizer’s 175th...
In phase 3 trials, Pfizer and BioNTech's vaccine showed strong immune responses against influenza A and COVID-19 but failed to meet key objectives for influenza B....
Seagen expects to generate $2.2 billion (€2.063 billion) in revenue in 2023 , which will represent a 12% year-on-year increase for the biotech company. Pfizer expects...
Roche is set to acquire Carmot Therapeutics, along with three clinical-stage assets for treating obesity and diabetes, for a maximum of €2.85 billion. The agreement involves...
In November, Moderna already confirmed its bad omens, recording losses of $3.6 billion in the third quarter of 2023, compared to the million dollars in revenue...
BioNTech 's turnover in 2022 was €17.31 billion, which represented a decrease of 8.8%. By business segments, those from the marketing of medicines amounted to €17.2...
Pfizer closed the first quarter of 2022 with a profit of $7.86 billion, up from $4.88 billion collected between January and March 2021. The pharma developer...
Pfizer is the only company that has a pneumococcal vaccine in Spain with an indication from six weeks of age. The tender budget has been determined...